Angiex is Drug Discovery in United States that focus on lead product business. Founded in 2015. They cover business area such as developer, vascular-target biotherapeutic, cancer, its platform, rapid development, Nuclear-deliver Antibody Drug Conjugates, conjugate payload, tumor cell, inflame vessel, healthcare provider, lung, glioblastoma multiforme.
2015
( 9 years old in 2024 )
Lead Product
-
300 Baker Avenue
Suite 300
Concord, MA 01742
United States
Private
developervascular-target biotherapeuticcancerits platformrapid developmentNuclear-deliver Antibody Drug Conjugatesconjugate payloadtumor cellinflame vesselhealthcare providerlungglioblastoma multiforme
* We use standard office opening hours in near Angiex's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Angiex is Drug Discovery business from United States that founded in 2015 (9 years old in 2024), Angiex business is focusing on Lead Product.
Angiex headquarter office and corporate office address is located in 300 Baker Avenue Suite 300 Concord, MA 01742 United States.
Angiex was founded in United States.
In 2024, Angiex is currently focus on lead product sector.
Above is snippet of Google Trends for "lead product" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Angiex, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
